U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06959927) titled 'Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure' on March 27.
Brief Summary: Age, hyperglycemia, inflammation, and comorbidities (hypertension, diabetes, coronary disease) independently increase HF risk in hemodialysis patients. Targeted risk management reduces psychological distress, complications, and enhances care outcomes.
Study Start Date: Jan. 01, 2022
Study Type: INTERVENTIONAL
Condition:
Hemodialysis
Heart Failure
Intervention:
OTHER: Standard Care Group
Patients in this group received conventional hemodialysis care, including:
Continuous monitoring of ...